Sector: Pharmaceuticals & Biotechnology

Large Cap

Dr. Reddy's Labs Share Price

DRREDDY

₹1,172

1.00(0.09%)

7th Aug 2026 | 3:14 PM

NSE : DRREDDY

Open Free Demat Account

Dr. Reddy's Labs Performance

Price Movement

₹1172.00

₹1162.10

₹1172.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1172.00

₹1101.00

₹1414.90

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,172.00

Low₹1,162.10

Open at₹1,166.00

Prev Close₹1,171.00

Volumes10.72 L

Avg Price₹1,167.17

Lower Circuit₹1,133.30

Upper Circuit₹1,203.30

Historical Performance

3M High₹1,414.90

3M Low₹1,101.00

1 Yr High₹1,414.90

1 Yr Low₹1,101.00

3 Yr High₹1,421.49

3 Yr Low₹1,020.00

5 Yr High₹1,421.49

5 Yr Low₹730.80

Summary

As of 10-08-2026 07:46, Dr. Reddy's Laboratories Ltd. share price today is ₹0, with a change of ₹-1171.00 (-100.00%) from the previous close of ₹1171. The stock opened at ₹1166 and traded between ₹1162.1 and ₹1172, with a total traded volume of 1072438 shares. The company has a market capitalization of ₹97740.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1414.9 and ₹1101, respectively.

Dr. Reddy's Laboratories Ltd. valuation metrics include a P/E ratio of 30.3, EPS of ₹50.41, and book value of ₹2.60. Profitability indicators show ROE of 11.07% along with a dividend yield of 0.7%. Dr. Reddy's Laboratories Ltd. has reported revenue of ₹33227.9 Cr and net profit of ₹3222.2 Cr.

Dr. Reddy's Laboratories Ltd. technical indicators include Day RSI at 38.38, Day MFI at 48.05, Day ADX at 40.41. Additional indicators include Commodity Channel Index (CCI) at -31.6 and Williams %R at -46.28. Momentum indicators show Day MACD at -31.5, Day MACD Signal Line at -34.71, DayATR at 27.09. Rate of Change indicators for Dr. Reddy's Laboratories Ltd. include ROC125 at -0.97 and ROC21 at -13.19.

Exponential moving averages include EMA5 at ₹1169, EMA10 at ₹1171.5, EMA12 at ₹1175.3, EMA20 at ₹1194.1, EMA26 at ₹1206.8, EMA50 at ₹1236.9, EMA100 at ₹1255.2, EMA200 at ₹1259.2. Simple moving averages include SMA5 at ₹1169.5, SMA10 at ₹1157.3, SMA20 at ₹1187.1, SMA30 at ₹1240.8, SMA50 at ₹1257.5, SMA100 at ₹1268.4, SMA150 at ₹1262.1, SMA200 at ₹1259.7.

Support levels for Dr. Reddy's Labs are placed at First Support ₹1164.53, Second Support ₹1158.07, Third Support ₹1153.13. Resistance levels are seen at First Resistance ₹1175.93, Second Resistance ₹1180.87, Third Resistance ₹1187.33. Dr. Reddy's Laboratories Ltd. shareholding pattern shows promoter holding at 26.64%, FII holding at 20.67%, DII holding at 0%, public holding at 9.35%.

Dr. Reddy's Labs Fundamentals

Market Cap

High in industry

97,740.50 Cr.

PE Ratio (TTM)

Above industry Median

30.30

Dividend Yield

Above industry Median

0.70

Net Profit TTM

43% decr over last year

3,222.20

Net Profit Growth

43% decr over last year

3,222.20

PEG Ratio

Negative PEG TTM

-0.70

ROE

34% decr over last year

11.07

Operating Revenue TTM

33,227.90

Operating Revenue Growth

1% decr over last year

Book Value

Below industry Median

2.60

MFI

MFI is mid-range

48.05

RSI

RSI is mid-range

38.38

EPS (TTM)

50.41

Debt to Equity

0.17

Face Value

Operating Profit Margin Qtr.

18.41

Operating Profit Qtr.

859.90

Net Profit Qtr.

444.30

Operating Revenue Qtr.

8,099.80

PB Ratio

2.60

Dr. Reddy's Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	5,136.60	3,822	4,282.70	4,618.60	7,809.50
Operating Expense	4,687.70	4,200.80	4,183.10	4,138.30	3,972.50
Operating Profit	447.40	-499.90	99.60	480.30	3,837
Depreciation	317.70	318.50	314.30	294.80	279.80
Interest	73.10	54.30	41.40	33.40	19.20
Tax	92.30	-86.10	13.60	129	975.10
Net Profit	404.70	-219.40	90.60	387.30	2,961.20

Dr. Reddy's Labs Technicals

Dr. Reddy's Laboratories Ltd. EMA & SMA

₹1172.00

-4.00 (-0.34%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1169

Day EMA10 ₹1171.5

Day EMA12 ₹1175.3

Day EMA20 ₹1194.1

Day EMA26 ₹1206.8

Day EMA50 ₹1236.9

Day EMA100 ₹1255.2

Day EMA200 ₹1259.2

Dr. Reddy's Labs Support and Resistance

Resistance

First Resistance₹1175.93

Second Resistance₹1180.87

Third Resistance₹1187.33

Support

First Support₹1164.53

Second Support₹1158.07

Third Support₹1153.13

Technical Indicators

Day RSI38.38

Day MFI48.05

Day ADX40.41

Day Commodity Channel Index-31.60

William-46.28

Day MACD-31.50

Day MACD Signal Line-34.71

Day ATR27.09

Day ROC125-0.97

Day ROC21-13.19

Dr. Reddy's Labs Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	26.6	26.6	26.6	26.6	26.6	26.6
FII	25.8	25.3	24.7	22.3	21.1	20.7
DII	37.1	37.8	38.8	41.3	42.7	43.1
Public	10.2	10	9.6	9.5	9.3	9.4

Dr. Reddy's Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	8.22 L	13.65 L	60.22%
Week	10.04 L	17.88 L	56.13%
1 Month	14.62 L	29.07 L	50.29%
6 Month	11.84 L	23.56 L	50.24%

Dr. Reddy's Labs SWOT Analysis

Strengths9

Weakness13

Opportunity4

Threats5

Benjamin Graham Value Screen

Upcoming results with Rising Delivery Volumes

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Companies with Zero Promoter Pledge

Decrease in Provision in recent results

Dr. Reddy's Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
10 Jul, 2026	8	FINAL	10 Jul, 2026	Equity Share
10 Jul, 2025	8	FINAL	10 Jul, 2025	Equity Share
16 Jul, 2024	40	FINAL		Equity Share
11 Jul, 2023	40	FINAL		Equity Share
11 Jul, 2022	30	FINAL		Equity Share
09 Jul, 2021	25	FINAL		Equity Share
13 Jul, 2020	25	FINAL		Equity Share
15 Jul, 2019	20	FINAL		Equity Share
16 Jul, 2018	20	FINAL		Equity Share
17 Jul, 2017	20	FINAL		Equity Share

Dr. Reddy's Labs Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,558.70	₹840.50	₹1,356	₹1,982	₹2,456	₹209.80
% Change	1.65%	1.80%	-4.07%	2.34%	1.48%	0.75%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,002.34	₹2,192.49	₹9,683.45	₹14,737.88	₹9,205.28
Net Profit TTM (₹ Cr)	₹246.74	₹575.94	₹348.91	₹1,011.39	₹2,042.67	₹-313.62
PE TTM	102.90	80.70	86.00	36.30	48.90	-88.40
1 Year Return	216.16	13.96	78.2	36.17	-5.32	11.76
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3290.00

+0.90%

GLAND

Gland Pharma Ltd.

₹ 2581.60

-1.02%

LAURUSLABS

Laurus Labs Ltd.

₹ 1844.30

+0.78%

ALKEM

Alkem Laboratories Ltd.

₹ 5620.00

+0.40%

BIOCON

Biocon Ltd.

₹ 426.35

-2.35%

DIVISLAB

Divi's Laboratories Ltd.

₹ 8275.00

-0.89%

GRANULES

Granules India Ltd.

₹ 871.00

+3.86%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3480.00

+0.28%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1114.20

+0.56%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2279.10

+0.40%

WOCKPHARMA

Wockhardt Ltd.

₹ 2016.00

+2.08%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1658.00

+4.35%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1945.00

-0.31%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 22915.00

+6.37%

IPCALAB

Ipca Laboratories Ltd.

₹ 1734.30

+0.01%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8200.00

+1.54%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2591.80

+0.48%

PFIZER

Pfizer Ltd.

₹ 4850.00

-1.02%

ABBOTINDIA

Abbott India Ltd.

₹ 27810.00

-0.16%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4924.00

-0.65%

LUPIN

Lupin Ltd.

₹ 2363.50

-0.90%

CIPLA

Cipla Ltd.

₹ 1463.80

-0.89%

FAQ's on DRREDDY

What is the current share price of Dr. Reddy's Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Dr. Reddy's Laboratories Ltd. is ₹ 1172 on the NSE and ₹ 1172 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Dr. Reddy's Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Dr. Reddy's Laboratories Ltd. is approximately ₹ 97740.5 Cr.

What are the PE and PB ratios for Dr. Reddy's Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Dr. Reddy's Laboratories Ltd. is 30.3, and the Price-to-Book (PB) ratio is 2.6.

What is the 52-Week High and Low for Dr. Reddy's Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Dr. Reddy's Laboratories Ltd. shares was ₹ 1414.9, and the lowest price was ₹ 1101.

What is the current dividend yield for Dr. Reddy's Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Dr. Reddy's Laboratories Ltd. is 0.7%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Dr. Reddy's Laboratories Ltd.?

Significant shareholdings in Dr. Reddy's Laboratories Ltd. typically include entities such as:

Other Institutions
Promoter
FII
Mutual Funds
Public

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Dr. Reddy's Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Dr. Reddy's Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Dr. Reddy's Laboratories Ltd.?

Dr. Reddy's Laboratories Ltd. last declared a FINAL dividend of ₹ 8 per share for the financial period ending 2026. The record date was set as 2026-07-10, and the payment was/is scheduled around 2026-07-10. For the most current dividend announcements, refer to official company filings.